Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ribosome (mitoribosome) is a specialized ribosome located within mitochondria, responsible for translating proteins encoded by mitochondrial DNA (mtDNA). These proteins are essential components of the oxidative phosphorylation (OXPHOS) complexes involved in ATP production. Mitoribosomes are structurally and functionally distinct from both bacterial and cytoplasmic ribosomes, reflecting their unique evolutionary adaptation to synthesize hydrophobic membrane proteins. Mutations affecting mitoribosome components can lead to severe mitochondrial disorders due to impaired respiratory chain function, making it a potential drug target.
Inhibition of mitochondrial protein synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Ribosome (Mitoribosome).